Table 6.
Cluster of genes predicted to encode the synthesis of bioactive compounds in the genome sequences of the strains of this study based on the analysis of genome sequences with AntiSMASH 3.0 program.
| Cluster | Type | Size (bp) | Most similar known cluster (% of similarity) | MIB – ID* |
|---|---|---|---|---|
| Pseudomonas IA19T | ||||
| Cluster 3 | – | 13,912 | Bromophenols and Bromopryrroles biosynthetic genes (20%) | BGC0000891_c1 |
| Cluster 6 | – | 6,919 | Lipopolysaccharide biosynthetic genes (8%) | BGC0000774_c1 |
| Cluster 11 | Fatty acid | 19,493 | Pyoverdine biosynthetic genes (4%) | BGC0000413_c1 |
| Cluster 12 | – | 19,861 | Amphotericin biosynthetic genes (15%) | BGC0000015_c2 |
| Cluster 14 | – | 23,611 | Pyoverdine biosynthetic genes (1%) | BGC0000413_c1 |
| Cluster 22 | Saccharide | 31,526 | Pyoverdine biosynthetic genes (3%) | BGC0000413_c1 |
| Cluster 24 | Saccharide | 40,812 | Pseudopyronine A and Pseudopyronine B biosynthetic genes (62%) | BGC0001285_c1 |
| Cluster 25 | Terpene-Siderophore | 43,656 | Carotenoid biosynthetic genes (85%) | BGC0000642_c1 |
| Cluster 32 | Saccharide | 50,218 | Lipopolysaccharide biosynthetic genes (36%) | BGC0000776_c1 |
| Cluster 37 | – | 17,662 | PM100117 and 100118 biosynthetic genes (10%) | BGC0001359_c1 |
| Cluster 41 | – | 24,157 | 2-amino-4-methoxy-trans-3-butenoic acid biosynthetic genes (40%) | BGC0000287_c1 |
| Cluster 42 | – | 9,467 | Caryoynencin biosynthetic genes (16%) | BGC0000892_c1 |
| Cluster 47 | – | 13,041 | Alginate biosynthetic genes (100%) | BGC0000726_c1 |
| Pseudomonas A2-NA12 | ||||
| Cluster 1 | Saccharide, Fatty acid | 34,524 | 5′-hydroxystreptomycin biosynthetic genes (9%) | BGC0000690_c1 |
| Cluster 2 | – | 23,963 | Polysaccharide B biosynthetic gene (6%) | BGC0001411_c1 |
| Cluster 4 | – | 28,529 | Streptolydigin biosynthetic gene (5%) | BGC0001046_c1 |
| Cluster 14 | – | 25,995 | Lankacidin biosynthetic gene (13%) | BGC0001100_c1 |
| Cluster 16 | – | 12,110 | Alginate biosynthetic genes (100%) | BGC0000726_c1 |
| Cluster 22 | – | 14,085 | 9-methylstreptimidone biosynthetic gene (9%) | BGC0000171_c1 |
| Cluster 23 | NRPS | 52,992 | Pyoverdine biosynthetic genes (22%) | BGC0000413_c1 |
| Cluster 26 | Saccharide | 4,662 | Lipopolysaccharide biosynthetic genes (36%) | BGC0000776_c1 |
| Cluster 28 | Bacteriocin | 10,839 | Bacillomycin_biosynthetic_gene_cluster (20%) | BGC0001090_c1 |
| Cluster 34 | NRPS | 129,458 | Pyoverdine biosynthetic gene (18%) | BGC0000413_c1 |
| Pseudomonas A2-NA13 | ||||
| Cluster 3 | – | 10,565 | Lipopolysaccharide biosynthetic genes (5%) | BGC0000774_c1 |
| Cluster 5 | – | 23,657 | Polysaccharide B biosynthetic genes (6%) | BGC0001411_c1 |
| Cluster 6 | Bacteriocin | 10,839 | Bacillomycin B biosynthetic genes (20%) | BGC0001090_c1 |
| Cluster 7 | NRPS | 1,333,658 | Pyoverdine biosynthetic gene (21%) | BGC0000413_c1 |
| Cluster 13 | – | 18,593 | 9-methylstreptomidone biosynthetic gene (9%) | BGC0000171_c1 |
| Cluster 21 | – | 17,344 | Meilingmycin biosynthetic gene (3%) | BGC0000093_c1 |
| Cluster 27 | – | 25,977 | Lankacidin biosynthetic gene (13%) | BGC0001100_c1 |
| Cluster 28 | NRPS | 52,992 | Pyoverdine biosynthetic gene (21%) | BGC0000413_c1 |
| Cluster 31 | Saccharide | 46,647 | Lipopolysaccharide biosynthetic gene (36%) | BGC0000776_c1 |
| Cluster 38 | Fatty acid, Saccharide | 32,344 | 5′-hydroxystreptomycin biosynthetic gene (9%) | BGC0000690_c1 |
| Cluster 40 | – | 24,316 | Streptolydigin biosynthetic gene (5%) | BGC0001046_c1 |
*
Minimum Information about a Biosynthetic Gene Cluster repository.